{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12915878", "DateCompleted": {"Year": "2003", "Month": "10", "Day": "02"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "17"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0007-0920", "JournalIssue": {"Volume": "89", "Issue": "4", "PubDate": {"Year": "2003", "Month": "Aug", "Day": "18"}}, "Title": "British journal of cancer", "ISOAbbreviation": "Br J Cancer"}, "ArticleTitle": "Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis.", "Pagination": {"StartPage": "681", "EndPage": "686", "MedlinePgn": "681-6"}, "Abstract": {"AbstractText": ["Although several studies have found overexpression of epidermal growth factor receptor (EGFR) proteins EGFR and Her-2 in head and neck cancers, the clinical relevance of the finding varies. We examined the expression and clinical association of these molecules with oral squamous cell carcinoma in an area where betel chewing is prevalent. EGFR and Her-2 proteins were measured in 59 paired (grossly normal and cancer) tissues by an enzyme immunoassy method. The cutoff value for gene overexpression was defined as the level of mean expression in normal tissue plus two s.d. A total of 59% of the patients consumed alcohol, 90% smoked tobacco, and 90% chewed betel quid. Of the patients assayed, 34 (58%) and 24 (41%) had EGFR and Her-2 overexpression, with average 3.5- and 1.5-fold elevations. EGFR overexpression has been shown to be statistically associated with T stage, N stage, overall TMN stage, primary tumour depth, lymph node extra-capsular spread, and poor survival. Her-2 overexpression, however, did not demonstrate a similar association with clinicopathological parameters or therapeutic outcome. On multivariant analysis, EGFR overexpression (P=0.041) and N stage (P=0.024) were the only independent factors for overall survival. These results indicate that the molecular targeting therapy to EGFR may be a treatment for oral cavity cancer in the betel quid-chewing prevalent area."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Otorhinolaryngology, Section of Head and Neck Surgery, Chang Gung Memorial Hospital,Taoyuan, Taiwan."}], "Identifier": [], "LastName": "Chen", "ForeName": "I-H", "Initials": "IH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chang", "ForeName": "J T", "Initials": "JT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liao", "ForeName": "C-T", "Initials": "CT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "H-M", "Initials": "HM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hsieh", "ForeName": "L-L", "Initials": "LL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cheng", "ForeName": "A-J", "Initials": "AJ"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Br J Cancer", "NlmUniqueID": "0370635", "ISSNLinking": "0007-0920"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers, Tumor"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "ErbB Receptors"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Receptor, ErbB-2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Areca"}, {"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers, Tumor"}, {"QualifierName": ["etiology", "metabolism", "pathology"], "DescriptorName": "Carcinoma, Squamous Cell"}, {"QualifierName": ["metabolism"], "DescriptorName": "ErbB Receptors"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["etiology", "metabolism", "pathology"], "DescriptorName": "Mouth Neoplasms"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prevalence"}, {"QualifierName": [], "DescriptorName": "Prognosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptor, ErbB-2"}, {"QualifierName": [], "DescriptorName": "Surveys and Questionnaires"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Taiwan"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bei R, Pompa G, Vitolo D, Moriconi E, Ciocci L, Quaranta M, Frati L, Kraus MH, Muraro R (2001) Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol 195: 343\u2013348", "ArticleIdList": ["11673832"]}, {"Citation": "Chen CH (1987) An epidemiological study of oral squamous cell carcinoma in southern Taiwan. J Formosan Dent Assoc 10: 268\u2013274"}, {"Citation": "Chong KM (1966) Betel nut chewing and mouth cancer in Taiwan. Observation of the oral mucosa in the betel nut chewers. J Formosan Med Assoc 65: 79\u201385", "ArticleIdList": ["5221284"]}, {"Citation": "Christensen ME, Engbaek F, Therkildsen MH, Bretlau P, Nexo E (1995) A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer 72: 1487\u20131493", "ArticleIdList": ["PMC2034104", "8519664"]}, {"Citation": "Clayman GL, Lippman SM, Laramore GE, Hong WK (1996) Head and neck cancer. In: Cancer Medicine, Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum R (eds) pp 1645\u20131709. Philadelphia: Williams and Wilkins"}, {"Citation": "Colomer R, Shamon LA, Tsai MS, Lupu R (2001) Herceptin: from the bench to the clinic. Cancer Invest 19: 49\u201356", "ArticleIdList": ["11291556"]}, {"Citation": "Contreras DN, Cobos E, Lox CD (2002) Evaluation of the circulating fraction of the HER-2/neu oncogene in patients with cervical cancer. Eur J Gynaecol Oncol 23: 491\u2013495", "ArticleIdList": ["12556089"]}, {"Citation": "Daftary DK, Murti PR, Bhonsle RR, Gupta PC, Mehta FS, Pindborg JJ (1991) Risk factors and risk markers for oral cancers in high risk areas of the world. In: Oral Cancer: Detection of Patients and Lesions at Risk, Johnson NW (ed) pp 29\u201363. Cambridge: Cambridge University Press"}, {"Citation": "Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin L, Yarbro JW (1998) AJCC Cancer Staging Manual, 5th edn. Lippincott: Williams Wilkins"}, {"Citation": "Franceschi S, Talamini R, Barra S (1990) Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 50: 6502\u20136507", "ArticleIdList": ["2208109"]}, {"Citation": "Hsieh LL, Wang PF, Chen IH, Liao CT, Wang HM, Chen MC, Chang JTC, Cheng AJ (2001) Characteristics of mutations in the p53 genes in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 22: 1497\u20131503", "ArticleIdList": ["11532872"]}, {"Citation": "Johnson NW (1991) A global view of the epidemiology of oral cancer. In: Oral Cancer: Detection of Patients and Lesions at Risk, Johnson NW (ed) pp 3\u201326. Cambridge: Cambridge University Press"}, {"Citation": "Klijn JG, Berns PM, Schmitz PI, Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5253 patients. Endocr Rev 13: 3\u201317", "ArticleIdList": ["1313356"]}, {"Citation": "Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG (2002) Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res 8: 540\u2013548", "ArticleIdList": ["11839675"]}, {"Citation": "Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC (1995) Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24: 450\u2013453", "ArticleIdList": ["8600280"]}, {"Citation": "Li X, Lee NK, Ye YW, Waber PG, Schweitzer C, Cheng QC, Nisen PD (1994) Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 86: 1524\u20131529", "ArticleIdList": ["7932807"]}, {"Citation": "Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159\u20133167", "ArticleIdList": ["PMC313958", "10880430"]}, {"Citation": "Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics. CA Cancer J Clin 46: 5\u201327", "ArticleIdList": ["8548526"]}, {"Citation": "Pfeiffer P, Nexo E, Bentzen SM, Clausen PP, Andersen K, Rose C (1998) Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis. Br J Cancer 78: 96\u201399", "ArticleIdList": ["PMC2062940", "9662257"]}, {"Citation": "Robert F, Ezekiel MP, Spencer SA, Meredith RF, Bonner JA, Khazaeli MB, Saleh MN, Carey D, LoBuglio AF, Wheeler RH, Cooper MR, Waksal HW (2002) Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 19: 3234\u20133243", "ArticleIdList": ["11432891"]}, {"Citation": "Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19: 183\u2013232", "ArticleIdList": ["7612182"]}, {"Citation": "Shanmugaratnam K (1991) Histological typing of tumours of the upper respiratory tract and ear. International Histological Classification of Tumours, 2nd edn. Berlin: Spring-Verlag"}, {"Citation": "Shin DM, Donato NJ, Perez-Soler R, Shin HJC, Wu JY, Zhang P, Lawhorn K, Khuri FR, Glisson BS, Myers J, Clayman G, Pfister D, Falcey J, Waksai H, Mendelsohn J, Hong WK (2001) Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clin Cancer Res 7: 1204\u20131213", "ArticleIdList": ["11350885"]}, {"Citation": "Simon MA (2000) Receptor tyrosine kinases: specific outcomes from general signals. Cell 103: 13\u201315", "ArticleIdList": ["11051543"]}, {"Citation": "Slaughter DP, Southwick HW, Smejkal W (1953) \u2018Field cancerization\u2019 in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6: 963\u2013968", "ArticleIdList": ["13094644"]}, {"Citation": "Storkel S, Reichert T, Reiffen KA, Wagner W (1993) EGFR and PCNA expression in oral squamous cell carcinomas\u2013a valuable tool in estimating the patient's prognosis. Eur J Cancer B Oral Oncol 29B: 273\u2013277", "ArticleIdList": ["11706420"]}, {"Citation": "Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE (1994) Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer 9: 192\u2013206", "ArticleIdList": ["7515662"]}, {"Citation": "Vikram B (1994) Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 110: 564\u2013565", "ArticleIdList": ["6477272"]}, {"Citation": "Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525\u2013532", "ArticleIdList": ["2841597"]}, {"Citation": "Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Eng J Med 328: 184\u2013194", "ArticleIdList": ["8417385"]}, {"Citation": "Werkmeister R, Brandt B, Joos U (2000) Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas. Oral Oncol 36: 100\u2013105", "ArticleIdList": ["10889928"]}, {"Citation": "Widschwendter A, Tonko-Geymayer S, Welte T, Daxenbichler G, Marth C, Doppler W (2002) Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res 8: 3065\u20133074", "ArticleIdList": ["12374673"]}, {"Citation": "Wong DYK, Chang KW, Chen CF, Chang RCS (1990) Characterization of two new cell lines\u2013OC1 and OC2. J Oral Maxilofac Surg 48: 385\u2013390", "ArticleIdList": ["2156034"]}, {"Citation": "Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, Liu AR, Li L, Katz RL, Hung MC (1999) Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5: 4164\u20134174", "ArticleIdList": ["10632356"]}]}], "History": [{"Year": "2003", "Month": "8", "Day": "14", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "10", "Day": "3", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "8", "Day": "14", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "8", "Day": "12"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12915878", "PMC2376917", "10.1038/sj.bjc.6601171", "6601171"]}}], "PubmedBookArticle": []}